Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bradford Grimme
Observed institutions:
University of Pittsburgh,
UPMC Hillman Cancer Center
OpenAlex ID:
A5083015449
Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair
2011
·
Eva M. Goellner
, Bradford Grimme
, et al.
·
Cancer Research
·
155
Data from Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair
2023
·
Eva M. Goellner
, Bradford Grimme
, et al.
Supplementary Methods, Figures 1-6, Table 1 from Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair
2023
·
Eva M. Goellner
, Bradford Grimme
, et al.
Supplementary Methods, Figures 1-6, Table 1 from Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair
2023
·
Eva M. Goellner
, Bradford Grimme
, et al.
PDF
Data from Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair
2023
·
Eva M. Goellner
, Bradford Grimme
, et al.
Show more works
View as search
Works count:
5
Citation count:
155
H-index:
1
I10-index:
1
Year
Topic
Type